Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

RWE of 1st Line Treatment in Adults With AML From 18 to 70 Years Old.

NCT05127798 ·Status: UNKNOWN

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

NCT04460950 ·Status: RECRUITING

Transfusion in Adult Acute Myeloid Leukemia

NCT02899767 ·Status: COMPLETED

Acute Myeloid Leukemia Registry

NCT05979675 ·Status: RECRUITING

Assessing Refractoriness and Infectious Survival Events in AML

NCT06709235 ·Status: COMPLETED

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

NCT01015196 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

NCT03435341 ·Status: COMPLETED

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

NCT06459024 ·Status: RECRUITING

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies

NCT05772559 ·Status: RECRUITING

Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4

NCT02473146 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL

NCT07059156 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Study Comparing Allogeneic Hematopoietic Cell Transplantation Versus Best Available Standard of Care Therapy in Elderly Patients With Acute Myeloid Leukemia

NCT04822766 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML

NCT06418776 ·Status: RECRUITING ·Phase: PHASE3

The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission

NCT05339204 ·Status: RECRUITING ·Phase: NA

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

NCT01929408 ·Status: COMPLETED

Randomised Prospective Comparison of the NMA Allograft and the Traditional Allograft in Acute Myeloid Leukaemia

NCT00224614 ·Status: UNKNOWN ·Phase: PHASE3

Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia

NCT02844257 ·Status: COMPLETED

Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)

NCT00909168 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

An Open, Single Center, Randomized Controlled Clinical Study of UCB (Cord Blood) in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT05577611 ·Status: UNKNOWN ·Phase: PHASE1

Frequency and Risk Factors of Acute Myeloid Leukemia

NCT05787951 ·Status: UNKNOWN

Single-cell Dynamic Profiling in Adults With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. A THEMA Study"

NCT05304156 ·Status: RECRUITING

Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML

NCT05309018 ·Status: WITHDRAWN

Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments

NCT06764459 ·Status: RECRUITING

Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study

NCT07108530 ·Status: RECRUITING ·Phase: PHASE2

HCT Versus CT in Elderly AML

NCT00766779 ·Status: TERMINATED ·Phase: PHASE3